These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 411743)

  • 1. Role of cellwall vaccine in prophylaxis of tuberculosis.
    Pal DP; Shriniwas
    Indian J Med Res; 1977 Mar; 65(3):340-5. PubMed ID: 411743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
    Yamamoto K
    Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.
    Bretscher PA
    Immunol Today; 1992 Sep; 13(9):342-5. PubMed ID: 1466750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG: protection against infection with Mycobacterium tuberculosis.
    Mohapatra PR; Janmeja AK
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):825; author reply 826. PubMed ID: 16848348
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
    Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H
    Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive and curative tuberculosis immunization with antigenic fractions of M. tuberculosis].
    León AP; Cano C
    Rev Invest Salud Publica; 1973; 33(3-4):35-59. PubMed ID: 4208624
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrapulmonary BCG cell wall vaccination in mice.
    Reuman PD; Ayoub EM
    Microbios; 1987; 49(198):7-15. PubMed ID: 3550393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New studies of BCG: implications for tuberculosis vaccines.
    von Reyn CF
    Lancet Infect Dis; 2012 Apr; 12(4):259-60. PubMed ID: 22071251
    [No Abstract]   [Full Text] [Related]  

  • 13. BCG vaccine responses following simultaneous immunization against influenza and tuberculosis. 2nd report.
    Zykov MP; Subbotina TI; Kaplin NN
    Z Erkr Atmungsorgane; 1981 May; 157(2):165-80. PubMed ID: 6797135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis and BCG vaccination].
    Pele I; Dede M; Piţigoi D
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(1):55-9. PubMed ID: 21038707
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catch-up vaccination against tuberculosis: how effective and how expensive?
    Chellaiyan VG; DAS TK; C P; Upadhyay RP
    Natl Med J India; 2012; 25(6):354-5. PubMed ID: 23998867
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
    Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pretreatment of mice with BCG cell walls in saline on subsequent vaccination with BCG oil droplet vaccine.
    Meyer TJ; Anacker RL; Ribi E
    Cell Immunol; 1974 Oct; 14(1):52-65. PubMed ID: 4219589
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.